$2.17
-0.11-4.82%
Last update: Nov 3, 6:11 PM
Edesa Biotech Inc
EDSANASDAQ
The average analyst price target for Edesa Biotech is $13, 470.2% above the current price. The one analyst covering it rates it Buy. Targets range from $5 to $21. The latest change came on Jun 27, 2025, when HC Wainwright & Co. assumed coverage of Edesa Biotech with a Buy rating and a $5 price target.
Price Target Range — 7 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months
